Catherine A. Segal R.Ph., Vice President, Business Development
Ms. Segal was associated with Pfizer Inc., for the past 18 years where she held roles of increasing responsibility in new products development, marketing, business development, alliance management and technology acquisition. Her last role at Pfizer Consumer Healthcare was Vice President, Global New Business and Strategic Planning. Ms. Segal also is an expert in prescription to over-the-counter switches managing the successful transition of Zantac, Beconase, Zovirax and Diflucan in several markets. She has three granted patents during her tenure at Pfizer. Prior to her years at Warner-Lambert & Pfizer, she held marketing, new product development assignments at Schering-Plough, Block Drug Co. and Reed & Carnrick Laboratories. Her pharmacy degree is from Rutgers University and she holds an MBA from Fairleigh Dickinson University.